Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22154135 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22153264 | 0.92 | NR3C1 (0.34) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22152482 | 0.92 | NR3C1 (0.34) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22152573 | 0.92 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22152602 | 0.92 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22152571 | 0.92 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22152599 | 0.92 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22377593 | 0.91 | NR3C1 (0.36) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22152420 | 0.91 | SMN1; SMN2 (0.36) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL22153303 | 0.91 | SMN1; SMN2 (0.36) | SMN1; SMN2ALDH1A1LMNAHPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203625-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203625-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | SMN1; SMN2 4714/4885ALDH1A1 1500/4885LMNA 1535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.